Prospective observational study on the pharmacokinetic properties of the Irrua ribavirin regimen used in routine clinical practice in patients with Lassa fever in Nigeria

INTRODUCTION: Lassa fever (LF) is a severe and often fatal systemic disease in humans and affects a large number of countries in West Africa. Treatment options are limited to supportive care and the broad-spectrum antiviral agent ribavirin. However, evidence for ribavirin efficacy in patients with L...

Descripción completa

Detalles Bibliográficos
Autores principales: Erameh, Cyril, Edeawe, Osahogie, Akhideno, Peter, Eifediyi, Gloria, Omansen, Till F, Wagner, Christine, Sarpong, Francisca, Koch, Till, Wicha, Sebastian, Kurth, Florian, Duraffour, Sophie, Oestereich, Lisa, Pahlmann, Meike, Okogbenin, Sylvanus, Ogbaini-Emovon, Ephraim, Günther, Stephan, Ramharter, Michael, Groger, Mirjam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Infectious Diseases
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7200043/
https://www.ncbi.nlm.nih.gov/pubmed/32303517
http://dx.doi.org/10.1136/bmjopen-2020-036936

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7200043/
https://www.ncbi.nlm.nih.gov/pubmed/32303517
http://dx.doi.org/10.1136/bmjopen-2020-036936

Ejemplares similares